BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

800 related articles for article (PubMed ID: 23362266)

  • 1. Estrogen receptor α mediates proliferation of osteoblastic cells stimulated by estrogen and mechanical strain, but their acute down-regulation of the Wnt antagonist Sost is mediated by estrogen receptor β.
    Galea GL; Meakin LB; Sugiyama T; Zebda N; Sunters A; Taipaleenmaki H; Stein GS; van Wijnen AJ; Lanyon LE; Price JS
    J Biol Chem; 2013 Mar; 288(13):9035-48. PubMed ID: 23362266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estradiol and testosterone regulate arginine-vasopressin expression in SH-SY5Y human female neuroblastoma cells through estrogen receptors-α and -β.
    Grassi D; Bellini MJ; Acaz-Fonseca E; Panzica G; Garcia-Segura LM
    Endocrinology; 2013 Jun; 154(6):2092-100. PubMed ID: 23584859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen Modulates Bone Morphogenetic Protein-Induced Sclerostin Expression Through the Wnt Signaling Pathway.
    Kim RY; Yang HJ; Song YM; Kim IS; Hwang SJ
    Tissue Eng Part A; 2015 Jul; 21(13-14):2076-88. PubMed ID: 25837159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of estrogen receptor α and β on the expression of visfatin and retinol-binding protein 4 in 3T3-L1 adipocytes.
    Jung US; Jeong KJ; Kang JK; Yi K; Shin JH; Seo HS; Kim T; Kim SH; Hur JY
    Int J Mol Med; 2013 Sep; 32(3):723-8. PubMed ID: 23857051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of estrogen receptors α- and β-specific agonists and antagonists on cell proliferation and energy metabolism in human bone cell line.
    Somjen D; Katzburg S; Sharon O; Grafi-Cohen M; Knoll E; Stern N
    J Cell Biochem; 2011 Feb; 112(2):625-32. PubMed ID: 21268084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative regulation of estrogen signaling by ERβ and RIP140 in ovarian cancer cells.
    Docquier A; Garcia A; Savatier J; Boulahtouf A; Bonnet S; Bellet V; Busson M; Margeat E; Jalaguier S; Royer C; Balaguer P; Cavaillès V
    Mol Endocrinol; 2013 Sep; 27(9):1429-41. PubMed ID: 23885094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting estrogen receptor subtypes (ERα and ERβ) with selective ER modulators in ovarian cancer.
    Chan KK; Leung TH; Chan DW; Wei N; Lau GT; Liu SS; Siu MK; Ngan HY
    J Endocrinol; 2014 May; 221(2):325-36. PubMed ID: 24819599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor alpha and beta heterodimers exert unique effects on estrogen- and tamoxifen-dependent gene expression in human U2OS osteosarcoma cells.
    Monroe DG; Secreto FJ; Subramaniam M; Getz BJ; Khosla S; Spelsberg TC
    Mol Endocrinol; 2005 Jun; 19(6):1555-68. PubMed ID: 15802376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Differential ER-Alpha Versus ER-Beta Mediated Activation of eNOS in Ovine Uterine Artery Endothelial Cells.
    Pastore MB; Talwar S; Conley MR; Magness RR
    Biol Reprod; 2016 Jun; 94(6):139. PubMed ID: 27170438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel ligand-independent function of the estrogen receptor is essential for osteocyte and osteoblast mechanotransduction.
    Aguirre JI; Plotkin LI; Gortazar AR; Millan MM; O'Brien CA; Manolagas SC; Bellido T
    J Biol Chem; 2007 Aug; 282(35):25501-8. PubMed ID: 17609204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen modulates in vitro T cell responses in a concentration- and receptor-dependent manner: effects on intracellular molecular targets and antioxidant enzymes.
    Priyanka HP; Krishnan HC; Singh RV; Hima L; Thyagarajan S
    Mol Immunol; 2013 Dec; 56(4):328-39. PubMed ID: 23911387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.
    Cotrim CZ; Fabris V; Doria ML; Lindberg K; Gustafsson JÅ; Amado F; Lanari C; Helguero LA
    Oncogene; 2013 May; 32(19):2390-402. PubMed ID: 22751110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Methoxyestradiol, an endogenous 17β-estradiol metabolite, inhibits microglial proliferation and activation via an estrogen receptor-independent mechanism.
    Schaufelberger SA; Rosselli M; Barchiesi F; Gillespie DG; Jackson EK; Dubey RK
    Am J Physiol Endocrinol Metab; 2016 Mar; 310(5):E313-22. PubMed ID: 26732685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethanol impairs estrogen receptor signaling resulting in accelerated activation of senescence pathways, whereas estradiol attenuates the effects of ethanol in osteoblasts.
    Chen JR; Lazarenko OP; Haley RL; Blackburn ML; Badger TM; Ronis MJ
    J Bone Miner Res; 2009 Feb; 24(2):221-30. PubMed ID: 18847333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells.
    Kallio A; Guo T; Lamminen E; Seppänen J; Kangas L; Väänänen HK; Härkönen P
    Mol Cell Endocrinol; 2008 Jul; 289(1-2):38-48. PubMed ID: 18455292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of estrogen receptor-alpha and -beta in regulating leptin expression in 3T3-L1 adipocytes.
    Yi KW; Shin JH; Seo HS; Lee JK; Oh MJ; Kim T; Saw HS; Kim SH; Hur JY
    Obesity (Silver Spring); 2008 Nov; 16(11):2393-9. PubMed ID: 18719660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor-mediated enhancement of venous relaxation in female rat: implications in sex-related differences in varicose veins.
    Raffetto JD; Qiao X; Beauregard KG; Khalil RA
    J Vasc Surg; 2010 Apr; 51(4):972-81. PubMed ID: 20347696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen Receptor-β Mediates Estradiol-Induced Pregnancy-Specific Uterine Artery Endothelial Cell Angiotensin Type-2 Receptor Expression.
    Mishra JS; Te Riele GM; Qi QR; Lechuga TJ; Gopalakrishnan K; Chen DB; Kumar S
    Hypertension; 2019 Oct; 74(4):967-974. PubMed ID: 31378106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fulvestrant inhibits growth of triple negative breast cancer and synergizes with tamoxifen in ERα positive breast cancer by up-regulation of ERβ.
    Mishra AK; Abrahamsson A; Dabrosin C
    Oncotarget; 2016 Aug; 7(35):56876-56888. PubMed ID: 27486755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor-α but not -β or GPER inhibits high glucose-induced human VSMC proliferation: potential role of ROS and ERK.
    Ortmann J; Veit M; Zingg S; Di Santo S; Traupe T; Yang Z; Völzmann J; Dubey RK; Christen S; Baumgartner I
    J Clin Endocrinol Metab; 2011 Jan; 96(1):220-8. PubMed ID: 20962025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.